Posters on the topic "Pharmacology in neurorehabilitation"

Back
  • P 007
The role of LOX-1 in inflammatory activation of microglial under hypoxic-ischemic conditions
  • Yoshinori Aoki (Miyazaki/ JP; Tokyo/ JP)
  • P 046
Cost-effectiveness of Cerebrolysin Add-on Treatment for Neurorecovery After Ischemic Stroke
  • P 130
MELAS: Arginine and Citrulline, the perfect combination?
  • P 298
A Cohort Study Comparing Melatonin-users with Non-users in the treatment of Migraine Headaches
  • P 321
Cerebrolysin and repetitive transcranial magnetic stimulation after moderate-severe traumatic brain injury – Results from the CAPTAIN rTMS pilot study
  • P 387
Post COVID fatigue syndrome – Thesis for a pharmacological approach
  • P 457
Botulinum toxin-A for the treatment of trigeminal neuralgia or of neuropathic pain after craniotomy for malignant stroke – A case series
  • P 464
Illustrating the effect of EGB 761 on cognitive recovery in chronic acquired brain injury survivors: Case series
  • P 465
Effect of perinatal asphyxia (PA) on mpz and krox20 gene expression, and compound muscle action potential (CMAP) in sciatic nerve of rats. Effects of mesenchymal stem cell secretome (MSC-S) administration
  • P 524
Patients with tracheostomy in a Neurocritical care: clinical profile, post tracheostomy outcomes and secretion management